Assessment of Hospitalizations and Emergency Department Visits After Chimeric Antigen Receptor T-Cell Therapy Among Commercially Insured Patients

This cohort study examines the cumulative incidence of rehospitalizations and emergency department visits during the first 12 months after hospitalization for chimeric antigen receptor T-cell infusion among commercially insured patients.